comprehensive -WSS

comprehensive

author：fashion 2025-09-30 13:13:55 - browse：27

U.S. legislation that would sever ties with Chinese drugmakers would jeopardize the drug supply for millions of American patients if it’s passed, the biotechnology industry’s main trade group has told Congress.

Congress is considering legislation, called the BIOSECURE Act, that would make it difficult for Chinese contract development and manufacturing organizations to do business with biotechnology companies that work with the U.S. federal government. Biotechs hire Chinese CDMOs, as they’re often called, for services that include product manufacturing, development, formulation, packaging, and distribution.

The BIOSECURE Act would stop the federal government from contracting with, or providing grants to, companies that do business with so-called Chinese “companies of concern.” The impact of the legislation would depend in large part on who is in the White House. The White House’s Office of Management and Budget would determine which companies are blacklisted, but a handful of specific companies would automatically go on that list, including the biotech giant WuXi AppTec.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： NIH trials fail to test meaningful long Covid therapies, experts say

entertainment

leisure time

WSS

FDA warns medical device makers about rise in fabricated data

A biotech analyst on neuroscience, placebo effect, not over

Man killed during FBI raid in connection with threats against Biden, other officials

How to use technology to prevent future drug shortages

FDA warns medical device makers about rise in fabricated data

Hospitals are piloting generative AI tools as regulators play catch

Wikipedia

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

knowledge

Sports medicine is finally prioritizing gender equality

Flagship Pioneering startup Sonata Therapeutics lays off 21

Walensky prepares to leave CDC — and Congress — behind

A biotech analyst on neuroscience, placebo effect, not over

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Elevance, SCAN deals highlight health insurer acquisition scrutiny

Trump demands the U.S. pay no more for drugs than other countries … again

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

Medical records are filled with copy

Obamacare plans could cover weight loss drugs

hotspot

Why failed clinical trials don’t always spell doom for a new drug

South Korea throws huge K

The best solution to the drug shortages problem

Obamacare plans could cover weight loss drugs

A new drug could help frostbite victims avoid its ravages

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Wikipedia

entertainment

leisure time

leisure time